News & Updates

Metabolic dysfunction-associated fatty liver disease (MAFLD) can escalate the incidence of severe COVID-19, but no association between MAFLD and COVID-19 death has been confirmed, suggest the results of a meta-analysis.

Switching to abacavir/lamivudine plus rilpivirine (ABC/3TC + RPV) for maintenance therapy is a safe and effective option for patients with virologically suppressed HIV-1, according to a recent Singapore study.

The neutrophil-to-lymphocyte ratio (NLR) appears to have stronger prognostic value for the coronavirus disease 2019 (COVID-19) than for influenza and the respiratory syncytial virus (RSV), a recent study has found.

Interleukin (IL-6) receptor antagonists provide significant clinical benefit in coronavirus disease 2019 (COVID-19) patients with high baseline mortality risk, a recent study has found. In contrast, such agents pose considerable threat when baseline mortality risk is low.

Life expectancy has decreased during the COVID-19 pandemic, with more than 28 million excess life years of life lost in 2020 in 31 countries, according to a study, noting a higher rate in men than women.

During Singapore’s coronavirus disease 2019 (COVID-19) lockdown, older adults experienced a decrease in depressive symptoms accompanied by growing feelings of loneliness and lower physical activity (PA), according to a recent study.

In the treatment of patients with chronic hepatitis B (CHB), the novel tenofovir amibufenamide (TMF) is as good as tenofovir disoproxil fumarate (TDF) in terms of efficacy but with the advantage of better bone and renal safety, according to the results of a noninferiority trial.